Huge expectations in the use of TRAIL in cancer treatment were generated, since systemic administration of TRAIL in mice was shown to be not only effective in killing human breast or colon xenografted tumor cells, but also in causing less toxicity than FasL or TNF administration [113]. Here, FASLG is linked to cancer.